Browse by theme

💊 Pharma & Biotech

Drug pipelines, regulatory approvals, biotech markets, and healthcare capital flows.

💊 Pharma & BiotechJuly 13, 2026

Pharma & Biotech: M&A Accelerates, Layoffs and Funding Mark H1 Close

The week of July 6-13, 2026, saw continued M&A momentum with Novartis and Incyte deals, alongside Genentech layoffs and a Bayer equity infusion. Biosimilar adoption gained traction amid patent expirations, while regulatory actions included an FDA rejection and ARPA-H gene-editing funding. The sector closed H1 at a five-year high supported by deal flow and clinical progress.

AI Weekly Brief3 min

💊 Pharma & BiotechJuly 6, 2026

Pharma M&A and Private Biotech Financing Rise in Early July 2026

M&A activity accelerated with multiple deals announced across oncology and rare diseases, while private financing reached $200 million for eight companies. Regulatory updates included FDA acceptances and approvals alongside leadership changes and policy scrutiny over China collaborations. The week reflected continued sector momentum amid a holiday period.

AI Weekly Brief3 min